Editas Medicine, Inc.
EDIT
$2.82
$0.010.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 319.99% | -88.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 319.99% | -88.56% | |||
| Cost of Revenue | 14.66% | -35.78% | |||
| Gross Profit | 43.87% | -454.60% | |||
| SG&A Expenses | 13.38% | -9.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.19% | -28.18% | |||
| Operating Income | 20.44% | -78.39% | |||
| Income Before Tax | 27.03% | -344.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 27.03% | -344.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 27.03% | -344.52% | |||
| EBIT | 20.44% | -78.39% | |||
| EBITDA | 20.57% | -85.60% | |||
| EPS Basic | 40.13% | -341.52% | |||
| Normalized Basic EPS | 35.74% | -156.02% | |||
| EPS Diluted | 40.13% | -341.52% | |||
| Normalized Diluted EPS | 35.74% | -156.02% | |||
| Average Basic Shares Outstanding | 21.88% | 0.64% | |||
| Average Diluted Shares Outstanding | 21.88% | 0.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||